Journal profile · Pharmacology, Toxicology and Pharmaceutics-Pharmacology
Infectious Disorders - Drug Targets
ISSN 1871-5265 · eISSN 2212-3989 · Bentham
Infectious Disorders - Drug Targets: subscription journal; median 143 days to acceptance (52 articles, last 24 months); 52 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Infectious Disorders - Drug Targets is published by Bentham. By OpenAlex counts of its recent articles, its largest topics are SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies and Antibiotic Resistance in Bacteria, together about 29.2% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Pharmacology, Toxicology and Pharmaceutics-Pharmacology
Main research topics OpenAlex counts of recent articles; shares are approximate
- SARS-CoV-2 and COVID-19 ResearchMedicine10.2%
- COVID-19 Clinical Research StudiesMedicine10.1%
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology8.9%
- Tuberculosis Research and EpidemiologyMedicine6%
- Computational Drug Discovery MethodsComputer Science5.3%
- Antibiotic Use and ResistanceImmunology and Microbiology4.3%
- Infectious Diseases and TuberculosisMedicine4.3%
- Virology and Viral DiseasesMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Microbiology (medical) | Q3 | 92/147 | — |
| Pharmacology | Q3 | 213/328 | — |
| Molecular Medicine | Q4 | 142/179 | — |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 2.9LetPub ·
- SJR 2026-06
- 0.31LetPub ·
- SNIP 2026-06
- 0.38LetPub ·
- h-index
- 58OpenAlex ·
- i10-index
- 380OpenAlex ·
- 2-year mean citedness
- 1.37OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 1,298 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 41 | 0 | 781 |
| 2025 | 52 | 2 | 1,273 |
| 2024 | 110 | 8 | 1,460 |
| 2023 | 89 | 6 | 1,487 |
| 2022 | 116 | 2 | 1,511 |
| 2021 | 64 | 2 | 1,444 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
141 daysMedian, submission to acceptance · P25–P75 123 days – 175 days
- Acceptance to online
- median 258 days (46 articles)
- Submission to online
- median 416 days
- Sample
- 46 articles with submission and acceptance dates (176 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Bentham
- ISSN
- 1871-5265
- Electronic ISSN
- 2212-3989
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Infectious Disorders - Drug Targets
How long does peer review take at Infectious Disorders - Drug Targets?
Based on the dates recorded on 52 articles published between November 2024 and November 2026 (the last 24 months), the median time from submission to acceptance is 143 days (interquartile range 124–171 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Infectious Disorders - Drug Targets?
According to LetPub and DOAJ records, Infectious Disorders - Drug Targets is indexed in Scopus.
Is Infectious Disorders - Drug Targets open access, and what is the APC?
Infectious Disorders - Drug Targets is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .